| Metronomic chemotherapy: new rationale for new directions E Pasquier, M Kavallaris, N André Nature reviews Clinical oncology 7 (8), 455-465, 2010 | 734 | 2010 |
| Understanding microtubule dynamics for improved cancer therapy S Honore, E Pasquier, D Braguer Cellular and Molecular Life Sciences CMLS 62, 3039-3056, 2005 | 402 | 2005 |
| Metronomics: towards personalized chemotherapy? N André, M Carré, E Pasquier Nature reviews Clinical oncology 11 (7), 413-431, 2014 | 325 | 2014 |
| Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non–small cell lung cancer PP Gan, E Pasquier, M Kavallaris Cancer research 67 (19), 9356-9363, 2007 | 309 | 2007 |
| Microtubules: a dynamic target in cancer therapy E Pasquier, M Kavallaris IUBMB life 60 (3), 165-170, 2008 | 264 | 2008 |
| Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment E Pasquier, J Ciccolini, M Carre, S Giacometti, R Fanciullino, C Pouchy, ... Oncotarget 2 (10), 797, 2011 | 259 | 2011 |
| Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway E Pasquier, M Carré, B Pourroy, L Camoin, O Rebaï, C Briand, ... Molecular Cancer Therapeutics 3 (10), 1301-1310, 2004 | 197 | 2004 |
| β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma E Pasquier, J Street, C Pouchy, M Carre, AJ Gifford, J Murray, MD Norris, ... British journal of cancer 108 (12), 2485-2494, 2013 | 185 | 2013 |
| Has the time come for metronomics in low-income and middle-income countries? N André, S Banavali, Y Snihur, E Pasquier The Lancet Oncology 14 (6), e239-e248, 2013 | 173 | 2013 |
| Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells E Pasquier, S Honore, B Pourroy, MA Jordan, M Lehmann, C Briand, ... Cancer Research 65 (6), 2433-2440, 2005 | 164 | 2005 |
| Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment E Pasquier, N Andre, D Braguer Current cancer drug targets 7 (6), 566-581, 2007 | 163 | 2007 |
| The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis GR Campbell, E Pasquier, J Watkins, V Bourgarel-Rey, V Peyrot, ... Journal of Biological Chemistry 279 (46), 48197-48204, 2004 | 153 | 2004 |
| Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study E Pasquier, N André, J Street, A Chougule, B Rekhi, J Ghosh, DSJ Philip, ... EBioMedicine 6, 87-95, 2016 | 136 | 2016 |
| Predicting synergism of cancer drug combinations using NCI-ALMANAC data P Sidorov, S Naulaerts, J Ariey-Bonnet, E Pasquier, PJ Ballester Frontiers in chemistry 7, 509, 2019 | 135 | 2019 |
| The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1 AE Tee, D Ling, C Nelson, B Atmadibrata, ME Dinger, N Xu, T Mizukami, ... Oncotarget 5 (7), 1793, 2014 | 124 | 2014 |
| Microtubule-targeting agents in angiogenesis: where do we stand? E Pasquier, S Honoré, D Braguer Drug Resistance Updates 9 (1-2), 74-86, 2006 | 111 | 2006 |
| The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression AE Tee, B Liu, R Song, J Li, E Pasquier, BB Cheung, C Jiang, ... Oncotarget 7 (8), 8663, 2016 | 109 | 2016 |
| Tubulin proteomics: towards breaking the code P Verdier-Pinard, E Pasquier, H Xiao, B Burd, C Villard, D Lafitte, ... Analytical biochemistry 384 (2), 197, 2009 | 100 | 2009 |
| Targeting mitochondrial complex I overcomes chemoresistance in high OXPHOS pancreatic cancer R Masoud, G Reyes-Castellanos, S Lac, J Garcia, S Dou, L Shintu, ... Cell Reports Medicine 1 (8), 2020 | 99 | 2020 |
| Antiangiogenic concentrations of vinflunine increase the interphase microtubule dynamics and decrease the motility of endothelial cells B Pourroy, S Honoré, E Pasquier, V Bourgarel-Rey, A Kruczynski, ... Cancer research 66 (6), 3256-3263, 2006 | 97 | 2006 |
Maria KavallarisChildren's Cancer Institute and Australian Centre for NanoMedicine, UNSW Sydney在 ccia.unsw.edu.au 的电子邮件经过验证
